In addition, GATA3 is not a breast-specific marker that can label other common sources of tumors [39], including urothelial carcinomas, squamous cell carcinomas, lung adenocarcinoma, pancreatic adenocarcinomas, endocrine tumors, soft tissue sarcomas, and others. This evidence concerns the gene GATA3 and soft tissue sarcoma.